Literature DB >> 7597658

Gene therapy for respiratory diseases: potential applications and difficulties.

E W Alton, D M Geddes.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7597658      PMCID： PMC1021215          DOI： 10.1136/thx.50.5.484

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  29 in total

1.  Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.

Authors:  R G Crystal; N G McElvaney; M A Rosenfeld; C S Chu; A Mastrangeli; J G Hay; S L Brody; H A Jaffe; N T Eissa; C Danel
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

2.  Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

Authors:  J F Engelhardt; R H Simon; Y Yang; M Zepeda; S Weber-Pendleton; B Doranz; M Grossman; J M Wilson
Journal:  Hum Gene Ther       Date:  1993-12       Impact factor: 5.695

Review 3.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

4.  Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.

Authors:  J Zabner; L A Couture; R J Gregory; S M Graham; A E Smith; M J Welsh
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

5.  Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium.

Authors:  A Bout; M Perricaudet; G Baskin; J L Imler; B J Scholte; A Pavirani; D Valerio
Journal:  Hum Gene Ther       Date:  1994-01       Impact factor: 5.695

6.  Transfer and expression of the human interleukin-4 gene in carcinoma and stromal cell lines derived from lung cancer patients.

Authors:  J D Hunt; B A Pippin; R J Landreneau; W F Jacob; M T Lotze; J M Siegfried
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-11

7.  Pulmonary autograft in children: realized growth potential.

Authors:  R C Elkins; C J Knott-Craig; K E Ward; C McCue; M M Lane
Journal:  Ann Thorac Surg       Date:  1994-06       Impact factor: 4.330

8.  Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes.

Authors:  A Porgador; E Tzehoval; E Vadai; M Feldman; L Eisenbach
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-10

9.  High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.

Authors:  W W Zhang; X Fang; W Mazur; B A French; R N Georges; J A Roth
Journal:  Cancer Gene Ther       Date:  1994-03       Impact factor: 5.987

10.  Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

Authors:  Y Yang; F A Nunes; K Berencsi; E Gönczöl; J F Engelhardt; J M Wilson
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.